home / stock / envb / envb quote
Last: | $0.52 |
---|---|
Change Percent: | -5.83% |
Open: | $0.5533 |
Close: | $0.5522 |
High: | $0.5533 |
Low: | $0.5112 |
Volume: | 56,884 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.52 | $0.5533 | $0.5522 | $0.5533 | $0.5112 | 56,884 | 07-03-2024 |
$0.5522 | $0.6 | $0.5522 | $0.6 | $0.52 | 132,300 | 07-02-2024 |
$0.5834 | $0.6262 | $0.5834 | $0.639 | $0.561 | 117,934 | 07-01-2024 |
$0.6262 | $0.614 | $0.6262 | $0.6296 | $0.605 | 97,881 | 06-28-2024 |
$0.6296 | $0.659 | $0.6296 | $0.659 | $0.61 | 65,805 | 06-27-2024 |
$0.6394 | $0.6203 | $0.6394 | $0.6845 | $0.6124 | 59,596 | 06-26-2024 |
$0.6202 | $0.6541 | $0.6202 | $0.67 | $0.6141 | 103,120 | 06-25-2024 |
$0.669 | $0.62 | $0.669 | $0.67 | $0.62 | 92,760 | 06-24-2024 |
$0.6127 | $0.6605 | $0.6127 | $0.69 | $0.6127 | 132,547 | 06-21-2024 |
$0.6312 | $0.66 | $0.6312 | $0.7 | $0.6303 | 116,258 | 06-20-2024 |
$0.6709 | $0.7065 | $0.6709 | $0.7222 | $0.66 | 153,794 | 06-19-2024 |
$0.6709 | $0.7065 | $0.6709 | $0.7222 | $0.66 | 153,794 | 06-18-2024 |
$0.7001 | $0.735 | $0.7001 | $0.735 | $0.6704 | 241,938 | 06-17-2024 |
$0.74 | $0.7399 | $0.74 | $0.761 | $0.72 | 42,230 | 06-14-2024 |
$0.75 | $0.77 | $0.75 | $0.77 | $0.74288 | 26,658 | 06-13-2024 |
$0.7608 | $0.74 | $0.7608 | $0.788 | $0.721 | 74,186 | 06-12-2024 |
$0.74 | $0.7315 | $0.74 | $0.749 | $0.71 | 52,084 | 06-11-2024 |
$0.749 | $0.7601 | $0.749 | $0.7601 | $0.7317 | 63,256 | 06-10-2024 |
$0.76 | $0.75 | $0.76 | $0.78 | $0.73 | 111,752 | 06-07-2024 |
$0.765 | $0.7794 | $0.765 | $0.7799 | $0.7466 | 50,899 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Enveric Biosciences Inc Com Company Name:
ENVB Stock Symbol:
NASDAQ Market:
Enveric Biosciences Inc Com Website:
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB). The update note includes information on the Enveric Bioscience’s ma...
EB-003 is a novel, neuroplastogenic molecule designed to treat severe mental health disorders without the hallucinogenic effect typically associated with psychedelic-based compounds Enveric is advancing pre-clinical development of EB-003 with a pre-IND meeting targeted for early 2025 ...
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced that the Com...